Showing results (11-20 of 625) with videos related to
Sort By:
Pageof 63
Cancer Treatment Reviews|August 17, 2011
A role for maintenance therapy in managing sarcomaIsabelle Ray-Coquard, Axel Le CesneAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challengesJonathan A Ledermann, Isabelle Ray-CoquardCurrent Opinion in Oncology|May 24, 2023
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patientsMargherita Turinetto, Pierre Meeus, Isabelle Ray-CoquardCurrent Opinion in Oncology|June 26, 2021
Importance of guidelines and networking for the management of rare gynecological cancersAlexandra Lainé, Brunhilde Hanvic, Isabelle Ray-CoquardCurrent Opinion in Oncology|July 24, 2019
Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?Hélène Vanacker, Clémence Romeo, Isabelle Ray-CoquardBulletin Du Cancer|February 9, 2016
[Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?]Mojgan Devouassoux-Shisheboran, Catherine Genestie, Isabelle Ray-CoquardBulletin Du Cancer|April 21, 2012
[Iron deficiency and anemia in oncology]Florian Scotté, Vincent Launay-Vacher, Isabelle Ray-CoquardBulletin Du Cancer|July 9, 2004
[Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials]Jean-Paul Guastalla, Thomas Bachelot, Isabelle Ray-CoquardEuropean Journal of Cancer (Oxford, England : 1990)|November 28, 2016
European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomasJean-Yves Blay, Mehdi Brahmi, Isabelle Ray-CoquardBulletin Du Cancer|May 19, 2005
[Cyclooxygenase 2 and breast cancer. From biological concepts to clinical trials]Jean-Paul Guastalla, Thomas Bachelot, Isabelle Ray-CoquardPageof 63